Applied DNA Sciences, Inc. (APDN)
USD 0.23
(1.26%)
USD 0.23
(1.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.36 Million | 18.16 Million | 9.02 Million | 1.93 Million | 5.38 Million | 3.9 Million |
| Cost of Revenue | 7.83 Million | 13.11 Million | 4.09 Million | 720.9 Thousand | 877.61 Thousand | 1.2 Million |
| Gross Profit | 5.53 Million | 5.05 Million | 4.92 Million | 1.21 Million | 4.51 Million | 2.69 Million |
| Operating Expenses | 16.48 Million | 19.02 Million | 17.22 Million | 13.74 Million | 13.63 Million | 14.34 Million |
| Selling, General and Administrative Expenses | 12.75 Million | 15.09 Million | 12.61 Million | 10.13 Million | 10.27 Million | 11.04 Million |
| Research and Development Expenses | 3.73 Million | 3.92 Million | 3.76 Million | 3.32 Million | 2.96 Million | 2.75 Million |
| Other Expenses | - | -1.71 Million | 844.43 Thousand | 285.73 Thousand | 390.42 Thousand | -37 Thousand |
| Cost and Expenses | 24.32 Million | 32.13 Million | 21.31 Million | 14.46 Million | 14.51 Million | 15.54 Million |
| Operating Income | -10.95 Million | -13.96 Million | -12.29 Million | -12.53 Million | -9.12 Million | -11.64 Million |
| Interest Expense | - | - | - | 115.83 Thousand | 162.43 Thousand | 9615.00 |
| Income Tax Expense | - | 107.93 Thousand | 1.75 Million | -263.93 Thousand | 15 Thousand | 46.62 Thousand |
| Earnings before Tax | -10.02 Million | -8.27 Million | -14.27 Million | -13.02 Million | -8.61 Million | -11.69 Million |
| Net Income | -9.94 Million | -8.37 Million | -16.02 Million | -12.76 Million | -8.63 Million | -11.69 Million |
| Earnings Per Share Basic | -15.21 | -18.68 | -46.35 | -65.14 | -187.30 | -317.12 |
| Earnings Per Share Diluted | -15.21 | -18.68 | -46.35 | -65.14 | -187.30 | -317.12 |
| Weighted Average Shares Outstanding | 653.77 Thousand | 448.38 Thousand | 345.85 Thousand | 195.95 Thousand | 46.09 Thousand | 36.87 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 653.77 Thousand | 448.38 Thousand | 345.85 Thousand | 195.95 Thousand | 46.09 Thousand | 36.87 Thousand |
| Gross Margin | 0.41 | 0.28 | 0.55 | 0.63 | 0.84 | 0.69 |
| EBIT Margin | -0.72 | -1.18 | -1.07 | -6.54 | -1.39 | -2.85 |
| Profit Margin | -0.74 | -0.46 | -1.78 | -6.61 | -1.60 | -3.00 |
| EBITDA | -9.59 Million | -12.67 Million | -11.68 Million | -12.24 Million | -8.06 Million | -11.09 Million |
| Earnings Before Tax Margin | -0.82 | -0.77 | -1.36 | -6.49 | -1.69 | -2.98 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 797.51 Thousand | 929.63 Thousand | 891.16 Thousand | 779.73 Thousand | 13.36 Million | 2.91 Million |
| Cost of Revenue | 686.45 Thousand | 820.3 Thousand | 660.06 Thousand | 700.74 Thousand | 7.83 Million | 1.64 Million |
| Gross Profit | 111.06 Thousand | 109.32 Thousand | 231.09 Thousand | 78.99 Thousand | 5.53 Million | 1.26 Million |
| Operating Expenses | 3.45 Million | 3.72 Million | 4.02 Million | 4.24 Million | 16.48 Million | 4.12 Million |
| Selling, General and Administrative Expenses | 2.67 Million | 3 Million | 3.08 Million | 3.31 Million | - | 3.29 Million |
| Research and Development Expenses | 778.86 Thousand | 726.86 Thousand | 935.81 Thousand | 938.9 Thousand | - | 836.12 Thousand |
| Other Expenses | -101.00 | 4581.00 | -13.53 Thousand | -5754.00 | 642.00 | -3469.00 |
| Cost and Expenses | 4.14 Million | 4.54 Million | 4.68 Million | 4.95 Million | 24.32 Million | 5.77 Million |
| Operating Income | -3.34 Million | -3.61 Million | -3.78 Million | -4.17 Million | -10.95 Million | -2.85 Million |
| Interest Expense | - | - | - | -2 Million | - | - |
| Income Tax Expense | -30.29 Thousand | 132.02 Thousand | 52.57 Thousand | -23.38 Thousand | -75.85 Thousand | -14.42 Thousand |
| Earnings before Tax | 1.84 Million | -4.49 Million | -1.13 Million | -3.61 Million | -10.02 Million | -3.11 Million |
| Net Income | 1.87 Million | -4.47 Million | -1.18 Million | -3.59 Million | -9.94 Million | -3.09 Million |
| Earnings Per Share Basic | 0.47 | -5.13 | -1.80 | -5.29 | - | -4.80 |
| Earnings Per Share Diluted | 0.47 | -5.13 | -1.73 | -5.29 | - | -4.80 |
| Weighted Average Shares Outstanding | 4.01 Million | 871.31 Thousand | 657.14 Thousand | 678.44 Thousand | 653.77 Thousand | 645.42 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 4.01 Million | 871.31 Thousand | 683.67 Thousand | 678.44 Thousand | 653.77 Thousand | 645.42 Thousand |
| Gross Margin | 0.14 | 0.12 | 0.26 | 0.10 | 0.41 | 0.44 |
| EBIT Margin | -4.03 | -3.69 | -6.88 | -5.59 | - | -0.76 |
| Profit Margin | 2.36 | -4.81 | -1.33 | -4.61 | -0.74 | -1.06 |
| EBITDA | -3.21 Million | -3.43 Million | -6.12 Million | -4.36 Million | - | -2.23 Million |
| Earnings Before Tax Margin | -4.20 | -3.89 | -4.25 | -5.35 | -0.82 | -0.98 |
TARACHAND
7836
CIFL
5452
CHCO
3288